29.Sep.2011

OCT has obtained an approval for starting-up a Phase III trial in multiple myeloma in 8 sites in Russia, 7 sites in Ukraine, 3 sites in Poland, 1 site in Lithuania

OCT has obtained an approval for starting-up a Phase III trial in multiple myeloma in 8 sites in Russia, 7 sites in Ukraine, 3 sites in Poland, 1 site in Lithuania
OCT has obtained an approval for starting-up a Phase III trial in multiple myeloma in 8 sites in Russia, 7 sites in Ukraine, 3 sites in Poland, 1 site in Lithuania